Related Experiment Video
Updated: Apr 20, 2026
08:32
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
1.5K
RNA interference and its role in cancer therapy
Behzad Mansoori1, Siamak Sandoghchian Shotorbani1, Behzad Baradaran1
1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Advanced Pharmaceutical Bulletin
|December 2, 2014
Summary
RNA interference (RNAi) offers a promising gene silencing approach for cancer treatment. This technology targets cancer-causing genes, showing potential for personalized cancer therapeutics and improved patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer is a leading global cause of death, with limited survival rates for advanced stages despite significant research funding.
- Standard cancer treatments often fall short, especially for advanced disease, highlighting the need for novel therapeutic strategies.
Purpose of the Study:
- To explore the potential of RNA interference (RNAi) as a targeted gene silencing therapy for cancer.
- To evaluate the application of RNAi in targeting oncogenes and overcoming treatment resistance in various cancer models.
Main Methods:
- Utilizing RNA interference (RNAi) technology to silence specific genes involved in tumorigenesis.
- Investigating the effects of gene knockdown via RNAi in cell culture, animal models, and clinical trials.
Main Results:
- RNAi demonstrates significant antiproliferative and proapoptotic effects on cancer cells in preclinical and clinical studies.
- Targeting cancer-related genes with RNAi shows promise in addressing tumor resistance to chemotherapy and radiotherapy.
Conclusions:
- RNAi-based therapies are advancing, with several drugs entering clinical trials for cancer treatment.
- This gene silencing mechanism holds potential for developing personalized cancer therapeutics and improving patient survival rates.
Related Concept Videos
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:23RNA Interference
7.9K
7.9K
01:23RNA Interference
29.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
29.0K
02:15Experimental RNAi
8.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
01:38Nucleotide Excision Repair
6.0K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
6.0K